Rare Cancers | NFCR Blog

Rare cancers are those that affect fewer than 40,000 people per year in the U.S.* For multiple reasons, there is a gap in research support for rare cancers, which can limit research progress. Learn more about NFCR’s genomic approach which aims to benefit ALL types of cancers.

Origin Cells of Glioblastoma May Have Been Identified

In what could be a major breakthrough, scientists at the Korea Advanced…

Read more

Trending Improvements for Multiple Myeloma

While it may not be an extremely common cancer, multiple myeloma, awareness…

Read more

“Pink Drink” to Aid Brain Tumor Treatment

Approved in June 2017 by the U.S. Food and Drug Administration and…

Read more

November Is Pancreatic Cancer Awareness Month

Even in the company of other vicious diseases, pancreatic cancer is particularly…

Read more

Pediatric Cancer Drug Has 93 Percent Effectiveness

A new cancer drug, larotrectinib, has in a very early clinical trial…

Read more

Exercise for Sarcoma Patients

Exercise and stretching are important for everyone and at all times. They…

Read more

Sarcoma Awareness Month: Bringing Light to “the Forgotten Cancer”

We all know that a pink ribbon symbolizes the fight against breast…

Read more

Hot and Cold: A New Pancreatic Cancer Treatment?

It is established medical fact that either heating or freezing a cancer…

Read more

New Test Developed for Pre-Cancerous Barrett’s Esophagus

In recognition of Esophageal Cancer Awareness Month, this National Foundation for Cancer…

Read more